Statement–Argument — Should scientists be allowed to pursue human cloning? Arguments: I) Yes; cloning technologies may fight disease and help childless couples have a baby. II) No; high malformation rates in animal cloning and ethical concerns about “playing with nature” make it unacceptable. Choose the strong argument(s).
-
Aif only argument I is strong.
-
Bif only argument II is strong.
-
CIf either I or II is strong.
-
DIf neither I nor II is strong
-
ENone of these
Answer
Correct Answer: If either I or II is strong.
Explanation
Introduction / Context:Human cloning raises profound ethical, social, and biosafety questions. Strong arguments in this arena typically invoke consequentialist (benefit/harm) reasoning and deontological (dignity/natural-order) concerns. The test is whether each side independently presents a policy-relevant, defensible rationale.
Given Data / Assumptions:
- Therapeutic applications (e.g., tissue lines) differ from reproductive cloning; public debates often conflate them.
- Animal cloning has shown developmental abnormalities and low success rates.
- Infertility imposes real psychological and social burdens on families.
Concept / Approach:Argument I is strong in principle: potential medical breakthroughs and reproductive help are compelling interests. Argument II is also strong: safety evidence (malformations) and ethical limits warrant precaution. Because both sides offer substantial, independent considerations, either can be judged strong depending on the ethical framework and risk tolerance adopted.
Step-by-Step Solution:
1) Evaluate benefit claims (I): medical/reproductive gains → significant.2) Evaluate risk/ethics (II): non-trivial harms and dignity concerns → significant.3) Since both are policy-salient, mark “either.”Verification / Alternative check:Many jurisdictions permit tightly regulated therapeutic research while prohibiting reproductive cloning, reflecting the dual strength of both arguments.
Why Other Options Are Wrong:“Only I/Only II” ignore the other weighty dimension; “Neither” denies the stakes on both sides.
Common Pitfalls:Failing to distinguish therapeutic from reproductive cloning; policy can be differentiated.
Final Answer:If either I or II is strong.